Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint
(IC) proteins, which act as a potent suppressor of the immune system by a myriad of …
(IC) proteins, which act as a potent suppressor of the immune system by a myriad of …
The role of microenvironment in tumor angiogenesis
X Jiang, J Wang, X Deng, F Xiong, S Zhang… - Journal of Experimental …, 2020 - Springer
Tumor angiogenesis is necessary for the continued survival and development of tumor cells,
and plays an important role in their growth, invasion, and metastasis. The tumor …
and plays an important role in their growth, invasion, and metastasis. The tumor …
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Recently, immune checkpoint inhibitors (ICIs) therapy has become a promising therapeutic
strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects …
strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects …
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
MJ Ansari, D Bokov, A Markov, AT Jalil… - Cell Communication and …, 2022 - Springer
Abnormal vasculature is one of the most conspicuous traits of tumor tissue, largely
contributing to tumor immune evasion. The deregulation mainly arises from the potentiated …
contributing to tumor immune evasion. The deregulation mainly arises from the potentiated …
Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives
The microenvironment characteristics of solid tumors, renowned as barriers that harshly
impeded many drug-delivery approaches, were precisely studied, investigated, categorized …
impeded many drug-delivery approaches, were precisely studied, investigated, categorized …
[HTML][HTML] Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
Y Zhao, YN Zhang, KT Wang, L Chen - Biochimica et Biophysica Acta (BBA …, 2020 - Elsevier
Lenvatinib, a multi-target tyrosine kinase inhibitor (TKI), is an emerging first-line therapy for
hepatocellular carcinoma (HCC). Its application has changed the status of sorafenib as the …
hepatocellular carcinoma (HCC). Its application has changed the status of sorafenib as the …
Recent advances in glucose‐oxidase‐based nanocomposites for tumor therapy
M Wang, D Wang, Q Chen, C Li, Z Li, J Lin - Small, 2019 - Wiley Online Library
Glucose oxidase (GOx) can react with intracellular glucose and oxygen (O2) to produce
hydrogen peroxide (H2O2) and gluconic acid, which can cut off the nutrition source of …
hydrogen peroxide (H2O2) and gluconic acid, which can cut off the nutrition source of …
Recent advances in porphyrin-based MOFs for cancer therapy and diagnosis therapy
Z Wang, Q Sun, B Liu, Y Kuang, A Gulzar, F He… - Coordination Chemistry …, 2021 - Elsevier
Porphyrins and porphyrin derivatives have attracted significant interest in the fields of
catalysis, biosensing, gas storage, solar cells, and biomedical applications owing to their …
catalysis, biosensing, gas storage, solar cells, and biomedical applications owing to their …
The role of apelin in cardiovascular diseases, obesity and cancer
MB Wysocka, K Pietraszek-Gremplewicz… - Frontiers in …, 2018 - frontiersin.org
Apelin is an endogenous peptide identified as a ligand of the G protein-coupled receptor
APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by …
APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by …
Systemic treatments for metastatic cutaneous melanoma
S Pasquali, AV Hadjinicolaou, VC Sileni… - Cochrane Database …, 2018 - cochranelibrary.com
Background The prognosis of people with metastatic cutaneous melanoma, a skin cancer, is
generally poor. Recently, new classes of drugs (eg immune checkpoint inhibitors and small …
generally poor. Recently, new classes of drugs (eg immune checkpoint inhibitors and small …